Pathogen: clinical or host-associated sample from ... - BioSample

Pathogen: clinical or host-associated sample from Klebsiella pneumoniae

Identifiers: BioSample: SAMN40930636; Sample name: BWH_1830_K_pne; SRA: SRS20993254

Organism: Klebsiella pneumoniae
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Klebsiella/Raoultella group; Klebsiella; Klebsiella pneumoniae complex

Package: Pathogen: clinical or host-associated; version 1.0

Attributes

isolate	BWH_1830_K_pne
collected by	Brigham and Women's Hospital
collection date	2024
geographic location	USA:Boston
host	Homo sapiens
host disease	Respiratory infection
isolation source	tracheal aspirate
latitude and longitude	42.3362 N 71.1067 W
host age	37

BioProject: PRJNA278886
Retrieve all samples from this project

Submission: Brigham and Women's Hospital, Jay Worley; 2024-04-11

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing platform	Vendor	Laboratory typing method version or reagent	Testing standard
amikacin	susceptible	<=	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
amoxicillin-clavulanic acid	resistant	>=	32/16	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ampicillin	resistant	>=	32	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefepime	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefiderocol	susceptible	==	21	mm	disk diffusion				CLSI
cefoxitin	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftaroline	susceptible	==	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftazidime	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftriaxone	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ciprofloxacin	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
clindamycin	susceptible	==	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
erythromycin	resistant	>=	8	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
gentamicin	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
levofloxacin	susceptible	==	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
linezolid	susceptible	==	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
meropenem	resistant	==	8	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
minocycline	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
moxifloxacin	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
oxacillin	resistant	>=	4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
piperacillin-tazobactam	resistant	>=	128/4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
rifampin	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tetracycline	resistant	>=	16	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tigecycline	susceptible	<=	0.12	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tobramycin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
trimethoprim-sulfamethoxazole	susceptible	<=	9.5/0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
vancomycin	susceptible	==	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI

Accession:: SAMN40930636
ID:: 40930636

BioProject SRA Nucleotide

BioSample

National Center for Biotechnology Information

Result Filters

Send to:

Pathogen: clinical or host-associated sample from Klebsiella pneumoniae

Supplemental Content

Related information

Recent activity